![William K. Holstein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William K. Holstein
Plus aucun poste en cours
Profil
William K.
Holstein worked as a Senior Vice President of Business Development at Gemmus Pharma, Inc..
Mr. Holstein attended The University of Colorado where he earned an undergraduate degree.
Anciens postes connus de William K. Holstein
Sociétés | Poste | Fin |
---|---|---|
Gemmus Pharma, Inc.
![]() Gemmus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Gemmus Pharma Inc. develops pharmaceutical products for the treatment of infectious diseases. The firm focus on the development of pharmaceutical products for the treatment of influenza and other viral infectious diseases. It develops GP1001, a non-peptidic eiconsanoid analog that is used for the treatment of serious influenza infections that require hospitalization as either a stand-alone treatment or co-therapy with an antiviral drug, as oseltamivir. The company was founded by Daryl H. Faulds in 2007 and is headquartered in San Francisco, CA. | Directeur Financier/CFO | - |
Formation de William K. Holstein
The University of Colorado | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Gemmus Pharma, Inc.
![]() Gemmus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Gemmus Pharma Inc. develops pharmaceutical products for the treatment of infectious diseases. The firm focus on the development of pharmaceutical products for the treatment of influenza and other viral infectious diseases. It develops GP1001, a non-peptidic eiconsanoid analog that is used for the treatment of serious influenza infections that require hospitalization as either a stand-alone treatment or co-therapy with an antiviral drug, as oseltamivir. The company was founded by Daryl H. Faulds in 2007 and is headquartered in San Francisco, CA. | Health Technology |